CA2388614A1 - Preparations de principes actifs pharmaceutiques - Google Patents
Preparations de principes actifs pharmaceutiques Download PDFInfo
- Publication number
- CA2388614A1 CA2388614A1 CA002388614A CA2388614A CA2388614A1 CA 2388614 A1 CA2388614 A1 CA 2388614A1 CA 002388614 A CA002388614 A CA 002388614A CA 2388614 A CA2388614 A CA 2388614A CA 2388614 A1 CA2388614 A1 CA 2388614A1
- Authority
- CA
- Canada
- Prior art keywords
- active ingredient
- component
- dosage form
- weight
- solid dosage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne des formes galéniques pharmaceutiques solides contenant un principe actif sous forme de mélange physique d'au moins deux préparations différentes en termes d'état physique du principe actif.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19951617A DE19951617A1 (de) | 1999-10-26 | 1999-10-26 | Zubereitungen pharmazeutische Wirkstoffe |
DE19951617.0 | 1999-10-26 | ||
PCT/EP2000/010205 WO2001030372A2 (fr) | 1999-10-26 | 2000-10-17 | Preparations de principes actifs pharmaceutiques |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2388614A1 true CA2388614A1 (fr) | 2001-05-03 |
Family
ID=7926968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002388614A Abandoned CA2388614A1 (fr) | 1999-10-26 | 2000-10-17 | Preparations de principes actifs pharmaceutiques |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1223960A2 (fr) |
JP (1) | JP2004500343A (fr) |
CN (1) | CN1384753A (fr) |
CA (1) | CA2388614A1 (fr) |
DE (1) | DE19951617A1 (fr) |
PL (1) | PL354991A1 (fr) |
WO (1) | WO2001030372A2 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6465016B2 (en) * | 1996-08-22 | 2002-10-15 | Research Triangle Pharmaceuticals | Cyclosporiine particles |
AR033711A1 (es) * | 2001-05-09 | 2004-01-07 | Novartis Ag | Composiciones farmaceuticas |
DE102005026755A1 (de) * | 2005-06-09 | 2006-12-14 | Basf Ag | Herstellung von festen Lösungen schwerlöslicher Wirkstoffe durch Kurzzeitüberhitzung und schnelle Trocknung |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0816053B2 (ja) * | 1986-12-04 | 1996-02-21 | 大正製薬株式会社 | 貼付剤の製造方法 |
JPH0436237A (ja) * | 1990-06-01 | 1992-02-06 | Taiho Yakuhin Kogyo Kk | 抗腫瘍性複合製剤 |
DK0615444T3 (da) * | 1991-12-05 | 1996-07-08 | Alfatec Pharma Gmbh | Peroral indgivelsesform til peptidlægemidler, især insulin |
GB9325445D0 (en) * | 1993-12-13 | 1994-02-16 | Cortecs Ltd | Pharmaceutical formulations |
JP4189044B2 (ja) * | 1997-07-01 | 2008-12-03 | 大正製薬株式会社 | マルチプルユニットタイプ徐放性錠剤 |
-
1999
- 1999-10-26 DE DE19951617A patent/DE19951617A1/de not_active Withdrawn
-
2000
- 2000-10-17 PL PL00354991A patent/PL354991A1/xx unknown
- 2000-10-17 CN CN00814940A patent/CN1384753A/zh active Pending
- 2000-10-17 CA CA002388614A patent/CA2388614A1/fr not_active Abandoned
- 2000-10-17 JP JP2001532789A patent/JP2004500343A/ja not_active Withdrawn
- 2000-10-17 WO PCT/EP2000/010205 patent/WO2001030372A2/fr not_active Application Discontinuation
- 2000-10-17 EP EP00972786A patent/EP1223960A2/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
DE19951617A1 (de) | 2001-05-03 |
JP2004500343A (ja) | 2004-01-08 |
EP1223960A2 (fr) | 2002-07-24 |
WO2001030372A2 (fr) | 2001-05-03 |
PL354991A1 (en) | 2004-03-22 |
WO2001030372A3 (fr) | 2001-11-01 |
CN1384753A (zh) | 2002-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6599528B1 (en) | Mechanically stable pharmaceutical presentations form containing liquid or semisolid surface-active substances | |
JP6534979B2 (ja) | 低溶解性化合物の安定な複合体 | |
US8349366B2 (en) | Immediate release pharmaceutical granule compositions and a continuous process for making them | |
US6511681B2 (en) | Aqueous solubility pharmaceutical formulations | |
JP3722293B2 (ja) | 新規な薬学的固体分散物 | |
US7273624B2 (en) | Stable dosage forms containing ubiquinones | |
KR100694667B1 (ko) | 생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제 | |
WO2017103677A1 (fr) | Complexes du célécoxib et de ses sels et dérivés, procédé pour la préparation de ceux-ci et compositions pharmaceutiques contenant ceux-ci | |
KR20230107902A (ko) | Cgrp-활성 화합물에 대한 정제 제제 | |
KR100956583B1 (ko) | 유비데카레논의 고체분산체와 그 제조방법 및 이를포함하는 약제학적 조성물 | |
JP2013505222A (ja) | 親水性ポリマーと組み合わせたポリエーテルに基づく両親媒性コポリマーを含有する速溶性固体医薬製剤 | |
Aggarwal et al. | Solid dispersion as an eminent strategic approach in solubility enhancement of poorly soluble drugs | |
JP4926319B2 (ja) | 固体医薬剤形のための粉末形態の可溶化賦形剤 | |
CA2301042A1 (fr) | Systeme d'apport de medicaments a regulation micro-osmotique | |
CA2388614A1 (fr) | Preparations de principes actifs pharmaceutiques | |
US20210161877A1 (en) | Gastroprotected, hydrophobic formulation of at least one active principle and method for obtaining same | |
CA2253769C (fr) | Composes pharmaceutiques a base de fenofibrate | |
JP2002515415A (ja) | シクロスポリン製剤 | |
EP2540281A1 (fr) | Systèmes à auto-microémulsion solide | |
JP2813792B2 (ja) | マレイン酸イルソグラジン経口投与用製剤およびその製造法 | |
KR20210150501A (ko) | Hcv를 치료하기 위한 고체 약제학적 조성물 | |
MXPA01009542A (en) | Improved aqueous solubility pharmaceutical formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |